Evidence map›Paper›PMID 32162429›Full record

ArticleChemMedChem2020

Resolving Binding Events on the Multifunctional Human Serum Albumin.

Lea Wenskowsky, Michael Wagner, Johannes Reusch, Herman Schreuder, Hans Matter, Till Opatz, Stefan Matthias Petry

Open access · hybridAbstract read
In one paragraph

Article in ChemMedChem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lea WenskowskyInstitute of Organic Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, 55128, Mainz, Germany.
Michael WagnerSanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.
Johannes ReuschDynamic Biosensors GmbH, Lochhamer Straße 15, 82152, Martinsried/Planegg, Germany.
Herman SchreuderSanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.
Hans MatterSanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.
Till OpatzInstitute of Organic Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, 55128, Mainz, Germany.
Stefan Matthias PetrySanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.ORCID 0000-0001-5596-8543
Sanofi (Germany) · DEJohannes Gutenberg University Mainz · DEDynamic Biosensors (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physiological processes rely on initial recognition events between cellular components and other molecules or modalities. Biomolecules can have multiple sites or mode of interaction with other molecular entities, so that a resolution of the individual binding events in terms of spatial localization as well as association and dissociation kinetics is required for a meaningful description. Here we describe a trichromatic fluorescent binding- and displacement assay for simultaneous monitoring of three individual binding sites in the important transporter and binding protein human serum albumin. Independent investigations of binding events by X-ray crystallography and time-resolved dynamics measurements (switchSENSE technology) confirm the validity of the assay, the localization of binding sites and furthermore reveal conformational changes associated with ligand binding. The described assay system allows for the detailed characterization of albumin-binding drugs and is therefore well-suited for prediction of drug-drug and drug-food interactions. Moreover, conformational changes, usually associated with binding events, can also be analyzed.

Indexed as

4-Chloro-7-nitrobenzofurazanBinding SitesBoron CompoundsCrystallography, X-RayFluorescenceHumansIbuprofenLauric AcidsMolecular Dynamics SimulationMolecular StructureSerum Albumin, HumanWarfarin12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoic acid4,4-difluoro-4-bora-3a,4a-diaza-s-indacene4-Chloro-7-nitrobenzofurazanBoron CompoundsIbuprofenLauric AcidsSerum Albumin, HumanWarfarinalbumin bindingdrug interactionskinetics investigationsmulticolor assaysswitchSENSE technology

Identifiers

PMID32162429
PMCPMC7318646
OpenAlexW3012264335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.